References
Ferrari S, Zanella L, Alberghini M et al (2008) Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma. Pediatr Blood Cancer 50:752–756
Ogino W, Takeshima Y, Mori T et al (2007) High level of ezrin mRNA expression in an osteosarcoma biopsy sample with lung metastasis. J Pediatr Hematol Oncol 29:435–439
Salas S, Bartoli C, Deville JL et al (2007) Ezrin and alpha-smooth muscle actin are immunohistochemical prognostic markers in conventional osteosarcomas. Virchows Arch 451:999–1007
Salas S, de Pinieux G, Gomez-Brouchet A et al (2009) Ezrin immunohistochemical expression in cartilaginous tumours: a useful tool for differential diagnosis between chondroblastic osteosarcoma and chondrosarcoma. Virchows Arch 454:81–87
Xu-Dong S, Zan S, Shui-er Z et al (2009) Expression of Ezrin correlates with lung metastasis in Chinese patients with osteosarcoma. Clin Invest Med 32:E180–E188
Acknowledgement
We would like to acknowledge Elisa Alonso from the University of Valencia for the collaboration and technical assistance and Mr. David Harrison for the English language support.
Conflict of interest statement
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported
This study was performed with grants from European Union (EuroBoNet project, contract no. 018814).
Rights and permissions
About this article
Cite this article
Machado, I., Navarro, S., Giner, F. et al. Ezrin immunohistochemical expression in chondrosarcomas, osteosarcomas and Ewing sarcoma family of tumors. Virchows Arch 457, 87–89 (2010). https://doi.org/10.1007/s00428-010-0940-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-010-0940-6